The rapidly expanding field of Cell and Gene Therapies (CGT) has the potential to revolutionize curative treatments. However, robust processes and technologies of CGT manufacturing have been lacking in the field due to the significant process complexity. The intent of this presentation is to summarize current state of manufacturing processes, outstanding challenges in process control and potential mitigation strategies for further improvement in CGT industry.
understand the common practice in cell gene therapy
gain the high level summary of current issues in cell gene therapy manufacturing